Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, As Represented By”
2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8133859
SCGB3A2 as a growth factor and anti-apoptotic agent
granted -
US 8133917
Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform
granted -
US 8133495
Live attenuated antigenically marked classical swine fever virus
granted -
US 8124101
Genetically engineered swine influenza virus and uses thereof
granted -
US 8125225
Transmit profile control in MRI
granted -
US 8124592
Development of a preventive vaccine for filovirus infection in primates
granted -
US 8124105
Compositions, methods and kits relating to poxvirus subunit vaccines
granted -
US 8114852
N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
granted -
US 8114848
Immunomodulatory oligonucleotides
granted -
US 8110681
Compounds for the treatment of spinal muscular atrophy and other uses
granted -
US 8110192
Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency
granted -
US 8110352
Method of diagnosing and treating cancer using B-catenin splice variants
granted -
US 8106027
Development of a preventive vaccine for filovirus infection in primates
granted -
US 8101380
Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
granted -
US 8101172
Solenopsis invicta virus
granted -
US 8101739
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
granted -
US 8093343
Nitric oxide-releasing diazeniumdiolated compounds
granted -
US 8088787
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted -
US 8088729
Anti-viral griffithsin compounds, compositions and methods of use
granted -
US 8088379
Modified T cell receptors and related materials and methods
granted -
US 8084594
H2N3 influenza A viruses and methods of use
granted -
US 8084199
Method of diagnosing poor survival prognosis colon cancer using microRNA-21
granted -
US 8076100
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
granted -
US 8075903
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
granted